Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Símbolo de cotizaciónBDX
Nombre de la empresaBecton Dickinson and Co
Fecha de salida a bolsaOct 31, 2099
Director ejecutivoPolen (Thomas E)
Número de empleados72000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 31
DirecciónOne Becton Drive
CiudadFRANKLIN LAKES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07417-1880
Teléfono12018476800
Sitio Webhttps://www.bd.com/
Símbolo de cotizaciónBDX
Fecha de salida a bolsaOct 31, 2099
Director ejecutivoPolen (Thomas E)